Recent Finacing
Recent Raise
Sarcomatrix Therapeutics is a biopharma UNR spinout developing oral small‑molecule therapies for Duchenne muscular dystrophy and related neuromuscular disorders, advancing a lead program through IND‑enabling studies toward first‑in‑human trials.
